Literature DB >> 8314345

High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?

J C Reubi1, U Horisberger, J Laissue.   

Abstract

Somatostatin receptors were detected in peritumoral veins of various human cancer tissue specimens. Vascular and neoplastic tissue from 14 colonic adenocarcinomas, 13 carcinoids, 6 renal-cell carcinomas and 7 malignant lymphomas were analyzed for somatostatin receptors by use of quantitative receptor autoradiography. In colonic carcinoma specimens, the peritumoral vessels expressed a high density of somatostatin receptors, whereas the neoplastic tissue itself was receptor-negative in many cases. In contrast, the incidence and density of somatostatin receptors in peritumoral vessels was low in well-differentiated gastrointestinal and bronchial carcinoids, in contrast to the high density of such receptors in the carcinoid tumor tissue. Autochthonous vessels surrounding other tumors such as renal-cell carcinomas or malignant lymphomas also frequently expressed somatostatin receptors. In all cases, the somatostatin receptors were localized in veins, particularly in the smooth-muscle cell layer. They exhibited specific and high-affinity binding of somatostatin-14, somatostatin-28 and octreotide, suggesting a preferential expression of the SSTR2 receptor subtype. Since the vessels of normal non-neoplastic human tissues, e.g. of intestine or lymphatic organs, have few somatostatin receptors, the increased somatostatin receptor expression in peritumoral vessels observed in this study may be linked to the neoplastic process itself. The results suggest that somatostatin and somatostatin receptors may play a regulatory role for hemodynamic tumor-host interactions, possibly involving tumor stroma generation, tumor environment, angiogenesis and, particularly, vascular drainage of poorly differentiated neoplasms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314345     DOI: 10.1002/ijc.2910560513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  The diagnostic utility of somatostatin receptor scintigraphy in oncology.

Authors:  R Valkema; J Steens; F J Cleton; E K Pauwels
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors.

Authors:  Marie-Louise Fjällskog; Eva Ludvigsen; Mats Stridsberg; Kjell Oberg; Barbro Eriksson; Eva T Janson
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  Differential diagnosis of solitary pulmonary nodules based on 99mTc-EDDA/HYNIC-TOC scintigraphy: the effect of tumour size on the optimal method of image assessment.

Authors:  Anna Płachcińska; Renata Mikołajczak; Józef Kozak; Katarzyna Rzeszutek; Jacek Kuśmierek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-16       Impact factor: 9.236

4.  Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin.

Authors:  Massimo Dal Monte; Davide Martini; Chiara Ristori; Danilo Azara; Chiara Armani; Alberto Balbarini; Paola Bagnoli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-28       Impact factor: 3.000

5.  A "false positive" octreoscan in ileal Crohn's disease.

Authors:  Alberto Fernandez; Olga Tabuenca; Angeles Peteiro
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

6.  Alternative therapeutic options in patients with advanced gastrointestinal cancer.

Authors:  G C Wishart; T G Cooke
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

7.  Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae.

Authors:  S A Laws; A C Gough; A A Evans; M A Bains; J N Primrose
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results.

Authors:  M Raderer; G Hamilton; A Kurtaran; J Valencak; I Haberl; O Hoffmann; G V Kornek; F Vorbeck; M H Hejna; I Virgolini; W Scheithauer
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

9.  Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.

Authors:  G Weckbecker; F Raulf; D Bodmer; C Bruns
Journal:  Yale J Biol Med       Date:  1997 Sep-Dec

10.  Definition of the role of somatostatin receptor scintigraphy in gastrointestinal neuroendocrine tumor localization.

Authors:  R T Jensen; F Gibril; B Termanini
Journal:  Yale J Biol Med       Date:  1997 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.